Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acetophenone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110483222B reveals a solvent-free mechanochemical method for synthesizing acetophenones, offering significant cost reduction and enhanced safety for pharmaceutical intermediate manufacturing.
Patent CN104726355A details yeast spore biocatalysis for high-purity S-phenylethylene glycol. Offers cost reduction and supply reliability for pharmaceutical intermediates.
Patent CN113354521A reveals a one-step synthesis route for 2-methoxy-5-fluoro bromoacetophenone, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN101230363B details a novel recombinant E. coli strain for asymmetric synthesis. This report analyzes cost reduction and supply chain advantages for pharmaceutical intermediates.
Patent CN104774778A details recombinant Candida parapsilosis for high-purity (S)-phenylethylene glycol. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN112110804B reveals a novel synthesis route for 3,5-dihalo trifluoroacetophenone derivatives, offering high purity and scalable industrial production capabilities.
Patent CN105461538A details a safer Grignard route for m-trifluoromethyl acetophenone. This method offers significant cost reduction and supply chain reliability for agrochemical manufacturing.
Novel one-pot method using polyphosphoric acid offers high yields and short reaction times for scalable flavanone production.
Patent CN116262673B reveals solvent-free ball milling for alpha-bromoacetophenone. Enhances supply chain reliability and reduces environmental impact for pharmaceutical intermediates.
Patent CN114539040A reveals a green photocatalytic route for alpha-haloketones, offering scalable production and cost-effective supply chain solutions for pharma intermediates.
Patent CN111574350B reveals a novel photoinitiator matching LED wavelengths above 365nm, offering superior double bond conversion and cost-effective manufacturing for industrial coatings.
Patent CN111574350B details a novel photoinitiator matching LED wavelengths above 365nm, offering superior curing efficiency and cost-effective synthesis for industrial coatings.
Patent CN106255676A reveals a high-purity manufacturing method for liquid α-bromoacetophenone compounds, offering significant supply chain and cost advantages for electronic chemical manufacturing.
Patent CN103819358A reveals a novel synthesis route for hydroxy methoxy acetophenone derivatives offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN111892488A reveals a novel Friedel-Crafts route for high-purity Crizotinib intermediates, offering significant cost reduction and scalable manufacturing solutions.
Patent CN104830744A details a novel SD-AS coupled enzyme method for (R)-phenylglycol. Achieves 100% e.e. and 99.9% yield, offering significant cost reduction and supply reliability for pharmaceutical manufacturing.
Novel synthesis patent CN106278846B offers high purity pharmaceutical intermediate with scalable cost reduction and supply chain reliability for global buyers.
Novel synthesis route for Pranlukast intermediate offers high purity and simplified manufacturing. Reliable pharmaceutical intermediates supplier ensuring cost reduction and supply continuity.
Patent CN118726999B enables metal-free electrochemical synthesis. Delivers high-purity pharmaceutical intermediates with reduced cost and enhanced supply chain reliability.
Novel Friedel-Crafts method for high-purity pharmaceutical intermediates. Eliminates hydrolysis, reduces cost, ensures scalable supply chain continuity.